NO306781B1 - Imidazo[1,2-a]kinoksalinforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene til fremstilling av medikamenter - Google Patents

Imidazo[1,2-a]kinoksalinforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene til fremstilling av medikamenter

Info

Publication number
NO306781B1
NO306781B1 NO963337A NO963337A NO306781B1 NO 306781 B1 NO306781 B1 NO 306781B1 NO 963337 A NO963337 A NO 963337A NO 963337 A NO963337 A NO 963337A NO 306781 B1 NO306781 B1 NO 306781B1
Authority
NO
Norway
Prior art keywords
compounds
independently
image
imidazo
alkoxy
Prior art date
Application number
NO963337A
Other languages
English (en)
Other versions
NO963337D0 (no
NO963337L (no
Inventor
Lone Jeppesen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO963337D0 publication Critical patent/NO963337D0/no
Publication of NO963337L publication Critical patent/NO963337L/no
Publication of NO306781B1 publication Critical patent/NO306781B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO963337A 1994-02-11 1996-08-09 Imidazo[1,2-a]kinoksalinforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene til fremstilling av medikamenter NO306781B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK18394 1994-02-11
DK135194 1994-11-25
PCT/DK1995/000044 WO1995021842A1 (en) 1994-02-11 1995-01-30 Heterocyclic compounds and their preparation and use

Publications (3)

Publication Number Publication Date
NO963337D0 NO963337D0 (no) 1996-08-09
NO963337L NO963337L (no) 1996-10-11
NO306781B1 true NO306781B1 (no) 1999-12-20

Family

ID=26063483

Family Applications (1)

Application Number Title Priority Date Filing Date
NO963337A NO306781B1 (no) 1994-02-11 1996-08-09 Imidazo[1,2-a]kinoksalinforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene til fremstilling av medikamenter

Country Status (15)

Country Link
US (1) US5741785A (no)
EP (1) EP0743945B1 (no)
JP (1) JPH09508632A (no)
KR (1) KR970701192A (no)
CN (1) CN1045964C (no)
AT (1) ATE214069T1 (no)
AU (1) AU692524B2 (no)
CA (1) CA2182957A1 (no)
DE (1) DE69525738D1 (no)
FI (1) FI963130A (no)
HU (1) HUT76323A (no)
IL (1) IL112588A (no)
NO (1) NO306781B1 (no)
NZ (1) NZ281183A (no)
WO (1) WO1995021842A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0783506A1 (de) * 1994-09-30 1997-07-16 Basf Aktiengesellschaft Neue heterocyclische substituierte imidazolo-chinoxalinone, ihre herstellung und verwendung
FR2743363A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-a-ones substituees en position 2, leur preparation et les medicaments les contenant
DE19611476A1 (de) * 1996-03-22 1997-09-25 Basf Ag Neue heterocyclische substituierte Imidazolo-chinoxalinone, ihre Herstellung und Verwendung
IL125950A0 (en) * 1997-09-05 1999-04-11 Pfizer Prod Inc Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
US8299080B2 (en) * 2006-12-13 2012-10-30 Aska Pharmaceutical Co., Ltd. Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor
EP2114948B1 (en) * 2006-12-28 2014-06-25 AbbVie Inc. Inhibitors of poly(adp-ribose)polymerase
JPWO2023042888A1 (no) 2021-09-15 2023-03-23
JPWO2023042887A1 (no) 2021-09-15 2023-03-23

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2448541A1 (fr) * 1979-02-09 1980-09-05 Roussel Uclaf Nouveaux derives de l'oxoimidazoquinoxaline et leurs sels, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
GB2043637B (en) * 1979-02-09 1983-03-16 Roussel Lab Ltd Heterotricyclic derivatives
GB2043064B (en) * 1979-02-09 1983-04-13 Roussel Lab Ltd Oximidazoquinoxaline derivatives
US5055465A (en) * 1989-05-31 1991-10-08 Berlex Laboratories, Inc. Imidazoquinoxalinones, their aza analogs and process for their preparation
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
US5182386A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands
WO1993020077A1 (en) * 1992-04-03 1993-10-14 Yamanouchi Pharmaceutical Co., Ltd. Fused quinoxalinone derivative and pharmaceutical composition containing the same
DE4310523A1 (de) * 1993-03-31 1994-10-06 Basf Ag Imidazolo-chinoxalinone zur Behandlung zentralnervöser Erkrankungen
ATE173263T1 (de) * 1993-03-31 1998-11-15 Basf Ag Imidazolochinoxalinonderivate als eaa antagonisten
DE4329970A1 (de) * 1993-03-31 1994-10-06 Basf Ag Neue Imidazolo-chinoxalinone, ihre Hestellung und Verwendung

Also Published As

Publication number Publication date
EP0743945B1 (en) 2002-03-06
NO963337D0 (no) 1996-08-09
AU692524B2 (en) 1998-06-11
NZ281183A (en) 1998-05-27
IL112588A (en) 1999-07-14
CN1145071A (zh) 1997-03-12
ATE214069T1 (de) 2002-03-15
CN1045964C (zh) 1999-10-27
IL112588A0 (en) 1995-05-26
AU1805595A (en) 1995-08-29
HUT76323A (en) 1997-08-28
US5741785A (en) 1998-04-21
FI963130A (fi) 1996-10-09
EP0743945A1 (en) 1996-11-27
FI963130A0 (fi) 1996-08-09
WO1995021842A1 (en) 1995-08-17
JPH09508632A (ja) 1997-09-02
DE69525738D1 (de) 2002-04-11
NO963337L (no) 1996-10-11
KR970701192A (ko) 1997-03-17
HU9602203D0 (en) 1996-10-28
CA2182957A1 (en) 1995-08-17

Similar Documents

Publication Publication Date Title
YU85001A (sh) Derivati 5-fenil-pirimidina
ATE207064T1 (de) Benzodiazepinderivate
TW377354B (en) [1,2,4]triazolo[4,3-a]quinoxaline compounds, their preparation and use
NO306781B1 (no) Imidazo[1,2-a]kinoksalinforbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene til fremstilling av medikamenter
ATE180483T1 (de) Imidazo(1,2-a>indeno (1,2-e> pyrazinone antagonisten der ampa und nmda rezeptoren
DK0752992T3 (da) Imidazo[1,2-a]indeno[1,2-e]pyrazin-4-on-derivater og farmaceutiske præparater indeholdende disse derivater
PT902684E (pt) Derivados hexa-hidro-pirido(4,3-b)indolo utilizados como farmacos antipsicoticos
NO305439B1 (no) Pyrido(1,2,3-de)kinoksalinderivater og legemidler inneholdende disse
HUP0004671A2 (hu) 5-Szubsztituált-3-oxadiazolil-1,6-naftiridin-2(1H)-on-származékok és ezeket tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JULY 2003